(Q23919665)

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Stimulatory effect of cigarette smoking on the hydroxylation of 3,4-benzpyrene and the N-demethylation of 3-methyl-4-monomethylaminoazobenzene by enzymes in human placenta

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Inducibility of benzo( )pyrene hydroxylase in human skin by polycylic hydrocarbons.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Early indicators of response in biologically based risk assessment for nongenotoxic carcinogens

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

The genetics of aryl hydrocarbon hydroxylase induction in mice: A single gene difference between C57BL/6J and DBA/2J

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

The in vivo and in vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. Distinction between the "responsive" homozygote and heterozygote at the Ah locus

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Benzo[a]pyrene-initiated leukemia in mice. Association with allelic differences at the Ah locus

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Omeprazole treatment does not affect the metabolism of caffeine

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Specific and dose-dependent enzyme induction by omeprazole in human beings.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Effect of CYP1A2 deficiency on heterocyclic amine DNA adduct levels in mice

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Origins of individual variability in P4501A induction

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Tobacco and the global lung cancer epidemic

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Transcriptional activation by the mouse Ah receptor. Interplay between multiple stimulatory and inhibitory functions

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Cytochrome P450: what have we learned and what are the future issues?

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

The use of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Cloning of a Factor Required for Activity of the Ah (Dioxin) Receptor

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

The aryl hydrocarbon receptor complex

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Induction of cytochrome P4501A1.

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Cytochrome P450 activation of arylamines and heterocyclic amines

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Cytochrome P450: nature's most versatile biological catalyst

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

Induction of CYP1A1. The AhR/DRE paradigm: transcription, receptor regulation, and expanding biological roles

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021

The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects

1 reference

https://api.crossref.org/works/10.1124%2FDMD.107.015826

7 January 2021